Neurocognitive differences between drivers with type 1 diabetes with and without a recent history of recurrent driving mishaps  by Campbell, Laura K. et al.
International Journal of Diabetes Mellitus 2 (2010) 73–77Contents lists available at ScienceDirect
International Journal of Diabetes Mellitus
journal homepage: www.elsevier .com/locate / i jdmOriginal Article
Neurocognitive differences between drivers with type 1 diabetes with and without a
recent history of recurrent driving mishaps
Laura K. Campbell, Linda A. Gonder-Frederick, Donna K. Broshek, Boris P. Kovatchev, Stacey Anderson,
William L. Clarke, Daniel J. Cox *
University of Virginia Health System, Dept. of Psychiatry and Neurobehavioral Sciences, United States
a r t i c l e i n f o a b s t r a c tArticle history:
Received 13 April 2010
Accepted 25 May 2010
Keywords:
Type 1 diabetes mellitus
Driving
Neuropsychology
Hypoglycemia1877-5934  2010 International Journal of Diabetes M
doi:10.1016/j.ijdm.2010.05.014
* Corresponding author. Address: Box 800223, U
System, Charlottesville, VA 22908, United States. Tel.:
E-mail address: djc4f@virginia.edu (D.J. Cox).Objective: A subset of drivers with type 1 diabetes mellitus (T1DM) may be at signiﬁcant risk for hypo-
glycemia-related driving collisions and moving vehicle violations due to acute and chronic neurocogni-
tive impairment. The present study compared drivers with T1DM with and without a recent history of
multiple driving mishaps on a neurocognitive battery during euglycemia, progressive mild hypoglycemia,
and recovery from hypoglycemia, to determine whether neurocognitive measures differentiate the two
risk groups. We hypothesized that drivers with a history of multiple recent hypoglycemia-related driving
mishaps would demonstrate greater psychomotor slowing, both during hypoglycemia and euglycemia.
Study design: Participants were 42 adults with T1DM and were assigned to one of two groups: those
reporting no driving mishaps in the last year (History) and those reporting two or more (+History). Neu-
rocognitive testing was conducted before and repeated during a hyper-insulinemic clamping procedure.
Results: Not surprisingly, all drivers demonstrated a decrease in functioning across all neurocognitive
tasks during hypoglycemia. However, in contrast to the common belief that neurocognitive functions
return slowly and gradually following hypoglycemia, baseline neurocognitive functioning immediately
recovered upon return of BG to euglycemia for all subjects. Between-group analyses revealed that sub-
jects with a recent history of driving mishaps consistently demonstrated poorer performance on tasks
measuring working memory.
Conclusion: Working memory is a potential neurocognitive indicator that may help differentiate adults
with T1DM with and without a history of driving mishaps, predict future risk for driving mishaps, and
provide targeted intervention programs to address this critical public health issue.
 2010 International Journal of Diabetes Mellitus. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.1. Introduction
Worldwide, driving collisions account for 1.2 million fatalities
and 50 million injuries annually [1]. Drivers with type 1 diabetes
mellitus (T1DM) in both Europe and the United States have been
found to have 138% more collisions and 50% more moving vehicle
violations compared to their non-diabetic spouses [2]. In addition
to general collisions and moving vehicle violations, drivers with
T1DMcan have driving ‘‘mishaps” due to hypoglycemia that include
collisions, moving vehicle violations, impaired driving resulting in
someone else taking over control of the vehicle before a collision,
and ‘‘automatic driving” during which a person drives from point
A to point B only to ‘‘awake” with no recollection of the trip. When
415 drivers with T1DMwere followed prospectively for 12 months,
half of the sample reported at least one hypoglycemia-related driv-ellitus. Published by Elsevier Ltd.
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Oing mishap and half reported no such events [3]. Just as some indi-
viduals with T1DM are more vulnerable to experiencing episodes
of severe hypoglycemia, there is likely to be a subgroup of individu-
als who are at relatively higher risk for hypoglycemia-related driv-
ing mishaps [4]. For example, in a driving simulator study,
patients with type 1 diabetes and impaired hypoglycemic unaware-
ness made the decision to drive while hypoglycemic more fre-
quently than did patients with type 1 diabetes and normal
hypoglycemic awareness [5]. A prospective study of 98 drivers with
T1DM demonstrated that those who reported two or more driving
mishaps in the previous 6 months were most likely to experience
driving mishaps in the next 6 months [6]. In this study, drivers
who reported a history of drivingmishapswere found to have great-
er carbohydrate utilizationwhen confrontedwith a standard insulin
challenge, less epinephrine counter-regulation, and demonstrated
worse driving performance during hypoglycemia when compared
to those with no history of driving mishaps.
While severe hypoglycemia has a more obvious impact on
driving and contributes directly to fatal car collisions [7], mildpen access under CC BY-NC-ND license.
Table 1
Pre-study parameters of participants with and without a history of driving mishaps.
Variables HX +Hx p
N 22 16
Age 42 ± 12.9 42 ± 12.8 ns
% Female 34% 62% ns
Education/yrs 15 ± 2.6 16 ± 2.2 ns
HbA1c 7.1 ± 0.8 7.5 ± 0.9 ns
Yrs. with diabetes 21 ± 9.4 21 ± 10.8 ns
Insulin units/day 42 ± 15.5 42 ± 32.3 ns
BMI 27 ± 5.2 26 ± 4.2 Ns
% Hypoglycemia
unawareness (N)
82% (18) 75% (12) ns
Severe hypoglycemia in
past 12 months
0.5 ± 0.7 1.6 ± 2.2 <.03
% Subjective neuropathy (N) 23% (5) 44% (7) ns
% Objective neuropathy (N) 9% (2) 19% (3) ns
% Retinopathy (N) 41% (9) 25% (4) ns
% Laser eye therapy (N) 4% (1) 12% (2) ns
Years driving experience 27 27 ns
Miles driven/yr 18.5714 ± 12.040 17.7308 ± 16.133 ns
SMBG before drivinga 1 1.7 ns
Fast acting sugar in cara 2 2.9 ns
# Mild hypo while driving
in past 6 months
0.7 1.1 ns
# Driving mishaps in past 0 2.8 .0001
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factor. In an international survey study of over 340 T1DM drivers,
the occurrence of mild symptomatic hypoglycemia while driving
differentiated drivers with and without a history of driving mis-
haps [2]. Mild hypoglycemia has been shown to disrupt cogni-
tive-motor skills relevant to driving and can impair judgment
regarding the decision to drive [8–10]. It is possible that these
acute neurocognitive deﬁcits resulting from neuroglycopenia are
further compounded by the chronic neurocognitive impairments
associated with microvascular complications of T1DM (e.g.,
psychomotor slowing; diminished cognitive ﬂexibility) in some
individuals, making this subgroup more vulnerable to driving
mishaps [11].
The present study compared drivers with T1DM with and
without a recent history of multiple driving mishaps on a
neurocognitive battery during euglycemia, progressive moderate
hypoglycemia, and recovery from hypoglycemia, to determine
whether neurocognitive measures differentiate the two groups.
We speciﬁcally hypothesized that drivers with a history of multiple
recent hypoglycemia-related driving mishaps would demonstrate
greater impairment across neurocognitive domains, both during
hypoglycemia and euglycemia.year
Hypoglycemic nadir
(clamp)
2.74 ± .89 mmol/L 2.64 ±.28 mmol/L ns
Peak epinephrine during
hypoglycemia (clamp)
188 ± 3.01 pmol/l 1184.38 pmol/l =.05
a Mean ratings on 0 (never) to 4 (always) scales.
Table 2
Battery of neuropsychological tests administered before GCRC admission testing,
respective group means and contrast p levels.
Test Outcome
variable
History +History p
BG level pre testing mmol/L 9.39 ± 3.9 10.29 ± 4.3 .56
BG level post testing mmol/L 9.20 ± 3.7 9.19 ± 3.7 .94
PEG BOARD time Sec. 79.6 ± 15.4 82.1 ± 26.0 .74
Drops # pins 0.41 ± 0.73 0.37 ± 1.26 .92
WAIS-R Block Design Raw Score 34.99 ± 11.7 33.9 ± 7.5 .74
Digit symbol sub Raw Score, #
correct
58.21 ± 1.7 56.4 ± 12.5 .65
Digit Vigilance RED T Sec. 193.1 ± 6.8 198.4 ± 10.0 .66
BLUE T Sec. 200.0 ± 31.2 207.1 ± 41.0 .57
RED E Sec. 2.0 ± 2.7 2.7 ± 2.5 .432. Materials and methods
2.1. Subjects
Forty-two adults with T1DM (mean age = 42.5 ± 12, disease
duration = 21.6 ± 9.4 years, HbA1c = 7.4 ± 0.8%) were recruited
through regional advertisements. Inclusion criteria required that
subjects: (1) had T1DM for at least 1 year, (2) measured their blood
glucose P3 times a day, (3) were between the ages of 21 and 70,
(4) drove a minimum of 6000 miles year, and (5) either reported
no driving mishaps (History group) or reported having two or
more driving mishaps in the past year (+History group). Driving
mishaps were deﬁned as collisions, citations, ‘‘automatic” driving,
or required someone to take control of their vehicle due to hypo-
glycemia. Further, because we planned to induce progressive hypo-
glycemia (approximately 2.5 mmol/L) through insulin infusion and
to draw frequent blood samples during the protocol, exclusionary
criteria included (1) hematocrit <38% for males or <36% for fe-
males, (2) pregnancy, and (3) presence of an electronic pacemaker
or more than 5% atrial or ventricular ectopy. Four subjects prema-
turely discontinued prior to study completion; three subjects had
insufﬁcient I.V. access for the hyper-insulinemic clamp procedure,
and one subject experienced a lower extremity muscle twitch
resulting from acute or chronic hypomagnesemia. As illustrated
in Table 1, the + and History groups did not differ on any demo-
graphic (i.e., age, sex, year of education), diabetes, or driving
parameters with the exception of the number of driving mishaps
and episodes of severe hypoglycemia in the previous 12 months.BLUE E Sec. 2.2 ± 2.4 3.6 ± 3.4 .18
TMT Trails A Sec. 29.0 ± 11.8 30.8 ± 9.5 .62
TMT Trails B Sec. 62.3 ± 24.6 65.0 ± 17.8 .70
Serial Subtraction 1
(327)
# Correct 24.4 ± 8,6 18.9 ± 8.4 .06**
2 (325) # Correct 25.1 ± 8.3 19.1 ± 8.3 .03*
Verbal Fluency A # Words 8.9 ± 3.6 9.3 ± 3.3 .75
S # Words 11.5 ± 4.0 11.4 ± 3.6 .92
PASAT 4 s, out of 49 # Correct/49 40.3 ± 8.6 35.8 ± 8.9 .13
PASAT 2 s # Correct 37.2 ± 8.2 29.3 ± 11.2 .02*
Stroop-word Age corrected 94.5 ± 17.5 89.0 ± 12.8 .28
Stroop-color Age corrected 71.7 ± 14.2 67.7 ± 13.1 .37
Stroop-CW conﬂict Age corrected 39.5 ± 14.2 39.4 ± 11.1 .98
Note: Tests in bold were re-administered as part of the abbreviated battery repeated
six times during GCRC admission.
* p < .05.
** p < 1.0 (approaching signiﬁcance).2.2. Procedure
The current study was part of a larger study examining the im-
pact of progressive hypoglycemia on driving simulation perfor-
mance [8]. After acquiring approval from our institutional review
board (IRB) and obtaining informed consent, participants com-
pleted an outpatient screening evaluation including a medical his-
tory, physical examination, 12 lead EKG, and laboratory tests for
HbA1c, complete blood count, and comprehensive metabolic panel.
All procedures were in accordance with the ethical standards of the
IRB and with the Helsinki Declaration.
For the 48-h prior to admission, the subjects were encouraged
to avoid hypoglycemia. Their total insulin was reduced by 10%,routine blood glucose (BG) testing was increased to ﬁve times a
day, and the subjects were instructed to eat 10 g of glucose pro-
phylactically whenever blood glucose (BG) fell below 5.5 mmol/L.
Intermediate and long-acting insulins were discontinued 24- and
36-h prior to admission, respectively. During this pre-admission
period and also during hospital admission, only short and rapid-
acting insulins were used.
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Clinical Research Center (GCRC) at 4 PM on the evening prior to
the hyper-insulinemic clamping procedure. A neuropsychological
test battery was then administered during euglycemia by a trained
examiner to evaluate chronic neurocognitive functioning (see Ta-
ble 2 for a list of the neuropsychological measures). Subjects were
then provided with a standardized (50% carbohydrate, 20% protein
and 30% fat), eucaloric, caffeine-free evening meal at 6 PM and a
bedtime snack at 9 PM. Subjects were allowed to drink glucose-
free, caffeine-free drinks throughout the evening, and were asked
to go to bed around 11 PM. Subjects were not allowed to eat any
additional food during the hospitalization other than that provided
by the GCRC or that required to treat BG < 5.5 mmol/L. Two IV lines
were placed in the non-dominant hand and arm area for overnight
infusion of insulin and hourly blood sampling to maintain the glu-
cose between 5.6 and 8.3 mmol/L.
On the morning of testing, subjects were awakened at approxi-
mately 7AM and given time to perform basic hygiene. They re-
mained fasting until after the study procedures were completed.
An additional retrograde hand IV was inserted and activated char-
coal packets were afﬁxed to the ﬁngers and hand areas for arterial-
ized sampling of BG every 5 min and epinephrine every 10 min.
Euglycemia, with a plasma glucose goal of 6.1 mmol/L, was
achieved and maintained using variable dextrose infusion. After
glucose and insulin stabilization, the subjects performed the ﬁrst
brief 30 min of neurocognitive testing. This was a rehearsal/prac-
tice trial not used for data analysis. Subsequently, dextrose infu-
sion was slowed or discontinued to ensure a steady descent into
hypoglycemia at a BG rate of fall of .056 mmol/dl/min. At a BG of
5–5.6 mmol/L, the subject was asked to complete a second brief
cognitive battery (Fig. 1). Progressive hypoglycemia testing oc-
curred when BG reached 3.9 mmol/L and ended at a BG nadir orFig. 1. Study design of acute neurocognitive testing on each day of GCRC admission.
Table 3
Brief neuropsychological test results during euglycemia, hypoglycemia and recovery.
Hx Euglycemia Hypo
Pre-post BG (mmol/L)  5.6 ± 0.5 2.8 ±
+ 5.5 ± 0.3 3.0–
Tests
Serial subtraction  24.7 ± 8.7 18.3
+ 20.3 ± 9.6 14.2
Verbal ﬂuency  10.6 ± 3.2 8 .4
+ 10.4 ± 2.2 8.3 ±
PASAT, 2  14.4 ± 3.1 12.7
+ 13.6 ± 3.3 10.8
Stroop  67.2 ± 12.9 55.5
+ 63.7 ± 13.4 55.5
* p-Values of ANOVA examining the change in neurocognitive performance across the t
** p-Values of between-group differences on the neurocognitive tests across the three g2.5 mmol/L. Once the BG nadir was achieved, BG was returned to
euglycemia (5.6 mmol/L) and then the ﬁnal testing occurred.
2.2.1. Neuropsychological testing
The neurocognitive test battery administered prior to the 2-day
admission to the GCRC included the following measures: Grooved
Pegboard (visual-motor coordination), Wechsler Adult Intelligence
Scale-Revised (WAIS-R) Block Design subtest (visuospatial and
constructive ability), WAIS-R Digit Symbol subtest (psychomotor
speed), Digit Vigilance (rapid visual tracking), Trail Making Test
(psychomotor speed, attention, and cognitive ﬂexibility), Serial
Subtraction (attention and working memory), Verbal Fluency (ra-
pid word production), Paced Auditory Serial Addition Task (PASAT;
divided attention, information processing speed, and working
memory), and Stroop Test (selective attention). With the exception
of the 2 WAIS-R subtests, all of the neuropsychological measures
yield 2 or more scores. The abbreviated test battery administered
during acute euglycemia, mild hypoglycemia, and immediately
upon recovery from hypoglycemia during GCRC study included Se-
rial Subtraction, Verbal Fluency, PASAT, and Stroop Test (Table 2).
2.3. Data analysis
Independent samples t-tests were used to evaluate whether
+History and History subjects differed on the neurocognitive test
battery administered pre-admission. A repeated measures three
conditions (euglycemia 5.6 mmol/L vs. hypoglycemia 2.5 mmol/L
vs. recovery euglycemia 5.6 mmol/L)  2 groups (+History vs.
History group) analysis of variance (ANOVA) was conducted for
each of the repeated cognitive tests during GCRC admission to
identify differences in subtest performance on the abbreviated
neurocognitive test battery among the glycemic conditions and be-
tween the two driving risk groups. Given that no between-group
differences in age or education were identiﬁed, raw scores on the
neurocognitive measures were used in the analyses.
3. Results
Table 2 lists the mean raw scores for each test in the neurocog-
nitive test battery administered the evening before BG manipula-
tion and repeat testing at each glycemic level (euglycemia,
hypoglycemia nadir, and recovery euglycemia). For testing the
evening before BG manipulation, the +History group demonstrated
signiﬁcantly poorer performance on the second Serial Subtraction
subtest (t = 2.22, p = .03) and PASAT 2 s (t = 2.47, p = .02) than did
the History group. A marginally lower score was also found for
the ﬁrst Serial Subtraction subtest (t = 1.95, p = .06).
Next, ANOVAs were conducted for each of the repeated neuro-
cognitive measures during GCRC admission (see Table 3). For Serial
Subtraction, signiﬁcant main effects were found for conditionglycemia Recovery BG* p Group** p
0.3 5.7 ± 0.4 .001 .89
0.9 5.6 ± 0.5 .001 Ns.91
± 5.2 26.1 ± 7.9 .000 .000
± 6.7 21.1 ± 9.0
± 2.4 10.3 ± 3.3 .000 .27
3.3 10.3 ± 3.3
± 4.1 14.8 ± 2.8 .000 .009
± 4.1 14.8 ± 3.3
± 16.3 68.4 ± 15.1 .000 .2
± 13.0 64.6 ± 14.8
hree glycemic conditions during the clamping procedure.
lycemic conditions during the clamping procedure.
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the interaction was not signiﬁcant. Speciﬁcally, Serial Subtraction
performance was signiﬁcantly lower for both groups during hypo-
glycemia and signiﬁcantly lower for the +History group across all
three conditions when compared to the History group. Similar re-
sults were found for PASAT, with signiﬁcant main effects found for
condition (F = 8.23, p < .01) and History group (F = 6.68, p = .01).
PASAT performance was signiﬁcantly lower for both groups during
hypoglycemia and lower at all conditions for the +History group
when compared to the History group. For Verbal Fluency, a sig-
niﬁcant main effect was found for condition only (F = 11.99,
p < .01), with no signiﬁcant main effect for History group or an
interaction. Likewise, for Stroop, only a main effect was found for
condition (F = 13.60, p < .01), with no main effect for History group
or an interaction. For the Stroop Test, as well as Verbal Fluency,
performance was signiﬁcantly lower at hypoglycemia for both
groups, but no signiﬁcant between-groups difference was found.
There was no signiﬁcant difference between baseline and recovery
performance on any of the repeated neurocognitive measures for
either group.
4. Conclusions
On all four neurocognitive measures repeated at euglycemia,
hypoglycemia, and recovery, performance decreased signiﬁcantly
during hypoglycemia regardless of group. This ﬁnding is not sur-
prising given the numerous studies demonstrating that hypoglyce-
mia is associated with neurocognitive deﬁcits in children and
adults with T1DM in the literature [12,13]. One ﬁnding of the pres-
ent study that was unique is that it demonstrated a return to base-
line neurocognitive functioning immediately upon return of BG to
euglycemia, regardless of driving history group. It is widely be-
lieved, with some empirical support in the literature, that recovery
of neurocognitive functioning following hypoglycemia is a slow
and gradual process, possibly taking up to 1.5 days [14,15]. The
only other study to our knowledge to also demonstrate a return
to baseline functioning upon return to euglycemia employed an
admittedly simple cognitive task assessing selective attention
[16]. The present study provides preliminary evidence that individ-
uals with type 1 diabetes may rapidly recover higher-level execu-
tive functions, such as cognitive ﬂexibility and working memory,
immediately after returning to euglycemia following hypoglyce-
mia when the hypoglycemia conditions is brief.
With regard to between-group differences and implications for
driving behavior, subjects with T1DM who were considered to be
at high risk for driving mishaps (+History) consistently demon-
strated poorer performance compared to the lower risk group
(History) on the Serial Subtractions and PASAT regardless of their
glycemic condition (i.e., at pre-admission and during euglycemia,
nadir, and recovery from hypoglycemia). None of the other neuro-
cognitive tests showed signiﬁcant group differences pre-admission
or during BG manipulation. What distinguishes the Serial Subtrac-
tion and PASAT tests from the remainder of the battery is that
these tasks assess working memory, the ability to temporarily
store and mentally manipulate information. In these neurocogni-
tive tasks, participants were required to remember auditorily-pre-
sented information and quickly perform simple mental arithmetic
problems based on temporarily stored bits of numeric information.
While hypoglycemia has been associated with working memory
impairment [13], to our knowledge, this study is the ﬁrst to exam-
ine decrements in working memory in relation to driving in diabe-
tes. Future research should be conducted to determine if working
memory is a potential neurocognitive indicator that differentiates
adults with T1DM with and without a history of driving mishaps.
It is unclear why individuals with T1DM who have a history of
two or more driving mishaps over the last 2 years demonstratepoorer working memory, even during euglycemia. The groups did
not differ on any demographic, diabetes, or driving variables, ex-
cept for recent history of severe hypoglycemia and hypoglycemia
driving mishaps. Due to the small sample size of the study, how-
ever, statistical power was not adequate to covary for these demo-
graphic and medical variables in the statistical analyses. It is
possible that the +History group has a greater absolute deﬁcit in
working memory based on the fact that they demonstrated poorer
performance on the above-mentioned measures before the hyper-
insulinemic clamping procedure when compared to the History
group. If this is the case, it may be that this absolute deﬁcit in
working memory exceeds a threshold during hypoglycemia that
is essential for safe driving. The ﬁndings do not suggest a general
deﬁcit that could be attributable to neuropathy, retinopathy, or
other complications of diabetes given that the + and History
groups did not differ on other neurocognitive measures.
While the role of working memory in driving performance has
not been studied extensively, one study examining left turn perfor-
mance at intersections in a simulated driving task found that work-
ing memory is associated with the ability to successfully judge and
choose gaps in oncoming trafﬁc prior to making a left turn [17].
Interestingly, greater working memory performance was associ-
ated with longer decision time in this study, which the authors
suggest may reﬂect the tendency of individuals with better work-
ing memory ability to allow more time to gather relevant informa-
tion before deciding to proceed through an intersection. In
contrast, the authors speculate that individuals with poorer work-
ing memory are less able to hold and process all relevant informa-
tion and therefore may make more hurried decisions to execute a
left turn. This study highlights the process by which working mem-
ory may mediate driving performance, as well as a speciﬁc driving
domain (left turn performance) on which to focus in future re-
search examining working memory and driving performance in
T1DM individuals with and without driving mishaps. Future stud-
ies should also attempt to replicate and extend the present study
ﬁndings to identify speciﬁc neurocognitive indicators of driving
performance aimed at identifying T1DM individuals at high risk
for future driving mishaps.
While the present study provides only preliminary evidence
that performance on working memory measures may be used to
identify T1DM drivers at higher risk for future driving mishaps,
the relevance of this area of study to clinical practice and public
health is readily apparent. If speciﬁc neurocognitive predictors of
driving risk in individuals with T1DM can be established, such data
may be used to inform clinical assessment and intervention of
drivers at risk in the future. Given that increasingly more evidence
is indicating that only a subgroup of individuals with T1DM is at
higher risk for driving mishaps, the existing social stigma of driving
with diabetes may be reduced and existing driving restrictions for
individuals with T1DM may be reﬁned.Conﬂicts of interest
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